Icon

AROMASIN (nda020753)- (25MG)

EXEMESTANE PFIZER
25MG
No No
2011-Apr-01 Expired
None None
None No
AROMASIN is an aromatase inhibitor indicated for: • adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer who have received two to three years of tamoxifen and are switched to AROMASIN for completion of a total of five consecutive years of adjuvant hormonal therapy. • treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy
9 0 9
Total Other Developers 2
Drugs with Suitability No
25MG ** ** - - 7
NDA Sales Available Total Generic Sales Available
Yes 8
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ****-**** ******** ***. *********** **** ****** ****, ********, **** (**) *****, ****** ****** (***) ***
****** ***** ***** ***** *** *** *********** ***** ****** *********** ** ********, ****. ***, ********, *****, ***** (***) ***
****** ******* ****** ****** *** *********** ******** ******** ****, *** ********* ****, *********, , ******* (***) ***
****** ***** ****** ***** ************ ******* *********** **** **. *-*/*&* *******, (******* ******** ****) ******, ******* ***** *.*. **. **, ***-******, ****-*********, *********, ******* ******, ***** (***) ***
****** ****** ***** **** ******* ************* ******* *********** ****** ******* **** ******** ** *** *****, ******* ********, ****, *** ******* (***) ***
****** ***** ***** ******* *********** **** ** ****, *-*** ** *-***, *-*** ** *-***, **** ** *-***/*/*/*, *-****, *-***, *-***, *-***, ***** ********** ****, ********, *** ******, ***** (***) ***
****** ************ *** ************ ******* ******* *********** ************ ********, ****-**, ****** ***. ****& **** ** ****, ********* (*******), ********* (******), ********** ********, ********* ******, ***** (***) ***
****** **** **** ************** **., ***. (********** ********** ****) *********** **** ***** ****, ****-**** ****, *****, ******** ******, ***** (***) ***
****** ***** ****** ***** ****** ************ ******* *********** ****-*, **. **. ***, *** & ***, ******* *******, ********* ******, *******-**********, ********* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.